Bayer AG's 16.3 billion euro ($19.6 billion) offer for drugmaker Schering AG was embraced enthusiastically by its target Friday as German rival Merck abandoned its own takeover offer.

Bayer's bid late Thursday trumped Merck's hostile 14.9 billion ($17.9 billion) offer for Schering made on March 13.

* Read the full Associated Press story .

For reprint and licensing requests for this article, CLICK HERE.